In terms of revenue, Global Glioblastoma Multiforme Treatment Market is expected to grow at a CAGR of 12.67% over the forecast period (2021 – 2030). The study analyses the market in terms of revenue across all the major regions, which have been bifurcated into countries. Absolute Markets Insights has announced addition of an insightful analytical data to its massive repository titled Glioblastoma Multiforme Treatment Market. Global competitors also highlighted in the study in order to get a stronger and effective outlook of the competition at domestic as well as global regions. In addition, the report also provides comprehensive information based on primary and secondary research methods for accurate data exploration.
Key Companies Profiled:
- Merck & Co.Inc.
- Amgen Inc.
- Hoffmann-La Roche Ltd.
- Pfizer Inc.
- DelMar Pharmaceuticals
- NOXXON Pharma
- Teva Pharmaceutical Industries Ltd.
- Sun Pharmaceutical Industries Ltd.
- Arbor Pharmaceuticals
- LLC
- Amneal Pharmaceuticals
- Karyopharm Therapeutics Inc
- Sumitomo Dainippon Pharma Oncology
Get a link for more details of market report at @ https://www.industryglobalnews24.com/global-glioblastoma-multiforme-treatment-market-is-gaining-rising-demand-amongst-
GBM is highly devastating in nature, and can result in the death of an adult in under six months if the cancer is left undetected or untreated. Studies show that two out of a hundred thousand individuals are diagnosed with GBM every year. Based on a report by the Central Brain Tumor Registry of the United States (CBTRUS), the average age of diagnosis of GBM is around 64 years. In adults, GBM develops in the cerebrum, a region of the brain that is responsible for handling many critical neurological processes. The progression of the disease, especially in adults, can have negative impacts on the quality of life, and may require palliative care. The need for early diagnosis of the tumor in adults is highlighted by the fact that the tumor is treatable when it is relatively small in size, and this can prevent the onset of spillage of the tumor cells that results in bigger tumor cells in the surrounding region. Reports also show that the males being affected by GBM is 1.6 times higher as compared to females. Individuals of Caucasians descent are at a significantly higher risk of developing GBM, as compared to other races such as African-Americans, Asians, and American Indians. Also, the chances of the tumor in children is not common. The higher occurrence of GMB in adults is a major reason for their higher share in the global glioblastoma multiforme treatment market.
Glioblastoma Multiforme Treatment Market Segmentation:
By Type of Treatment
- Surgery
- Radiotherapy
- Chemotherapy
- Tumor treating fields (TTF) therapy
- Targeted drug therapy
- Supportive (palliative) care
- Others
By Mode of Action
- Immunological
- Metabolic
- Pharmacological
By Demographic
- Kids
- Adults
By End Users
- Hospitals and Clinics
- Research Institutes
- Pharmaceutical Companies
- Others
By Region
- North America
- Europe
- Asia Pacific
- Middle East and Africa
- Latin Americ
Contact Us:
Company: Absolute Markets Insights
Email Id: sales@absolutemarketsinsights.com
Phone: IN +91-740-024-2424, US +1-510-420-1213
Contact Name: Shreyas Tanna
Website: www.absolutemarketsinsights.com
No comments:
Post a Comment